Upstream Bio Inc (NASDAQ: UPB) started the day on Thursday, with a price increase of 4.60% at $19.79, before settling in for the price of $18.92 at the close. Taking a more long-term approach, UPB posted a 52-week range of $5.14-$29.46.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 50.04%. This publicly-traded company’s shares outstanding now amounts to $53.80 million, simultaneously with a float of $19.89 million. The organization now has a market capitalization sitting at $1.07 billion. At the time of writing, stock’s 50-day Moving Average stood at $17.55, while the 200-day Moving Average is $11.99.
Upstream Bio Inc (UPB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Upstream Bio Inc’s current insider ownership accounts for 63.10%, in contrast to 53.04% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’24, this organization’s Director bought 825,000 shares at the rate of 17.00, making the entire transaction reach 14,025,000 in total value, affecting insider ownership by 4,554,873. Preceding that transaction, on Oct 15 ’24, Company’s Director bought 825,000 for 17.00, making the whole transaction’s value amount to 14,025,000. This particular insider is now the holder of 4,554,873 in total.
Upstream Bio Inc (UPB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.77 per share during the current fiscal year.
Upstream Bio Inc’s EPS increase for this current 12-month fiscal period is 50.04% and is forecasted to reach -2.95 in the upcoming year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
Let’s observe the current performance indicators for Upstream Bio Inc (UPB). It’s Quick Ratio in the last reported quarter now stands at 38.27. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 392.23.
In the same vein, UPB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.05, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -2.95 at the market close of one year from today.
Technical Analysis of Upstream Bio Inc (UPB)
If we take a close look at the recent performances of Upstream Bio Inc (NASDAQ: UPB), its last 5-days Average volume was 0.35 million that shows plunge from its year to date volume of 0.38 million. During the previous 9 days, stock’s Stochastic %D was recorded 83.73% While, its Average True Range was 69.67.
Raw Stochastic average of Upstream Bio Inc (UPB) in the period of the previous 100 days is set at 90.12%, which indicates a major fall in contrast to 92.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.88 that was lower than 1.02 volatility it exhibited in the past 100-days period.
